Published online May 26, 2021. doi: 10.12998/wjcc.v9.i15.3576
Peer-review started: January 4, 2021
First decision: January 23, 2021
Revised: January 28, 2021
Accepted: April 8, 2021
Article in press: April 8, 2021
Published online: May 26, 2021
Processing time: 127 Days and 2.5 Hours
Surges of coronavirus disease 2019 (COVID-19) patients have markedly influenced the treatment policies of tertiary hospitals because of the need to protect medical staff and contain viral transmission, but the impact of COVID-19 on emergency gastrointestinal endoscopies has not been determined.
Endoscopy involves direct contact with patients’ body fluid, oropharyngeal mucosa and fecal fluid. Furthermore, endoscopic procedures can act as covert vehicles of transmission due to aerosol formation during endoscopic manipulations, and it is known that severe acute respiratory syndrome coronavirus-2 can survive in the gastrointestinal tract for more than 2 wk.
This study was undertaken to compare endoscopic activities and analyze the clinical outcomes of emergency endoscopies performed before and during the COVID-19 outbreak in Daegu City, the epicenter of the first serious outbreak in South Korea.
The medical records of patients that underwent endoscopy from February 18 to March 28, 2020, at a tertiary teaching hospital were retrospectively evaluated. Demographic data, laboratory data, chief complaints, types of endoscopies, causes of emergent endoscopies, and endoscopic reports were reviewed during the above-mentioned period and for the same periods during 2018 and 2019.
The number of emergent endoscopic procedures performed in 2020 was 48.8% and 54.8% lower than in 2018 and 2019, respectively. During the COVID-19 outbreak, the main indications for endoscopy were melena (36.7%), hematemesis (30.6%), and hematochezia (10.2%), and gastrointestinal bleeding was the most common endoscopic abnormalities detected (39 cases in 2018, 51 in 2019, and 35 in 2020).
The COVID-19 outbreak resulted in significant reductions in endoscopic procedures and changes in patient behaviors.
Long-term follow-up studies are required to determine the effects of COVID-19 induced changes in patient behaviors, endoscopy types, missed malignancies, disease progressions, and patient outcomes.